Dividends Calendar Earnings Calendar
NAVB

NAVB | Navidea Biopharmaceuticals, Inc.

Navidea Biopharmaceuticals, Inc.
  • Industry: Medical Appliances & Equipment

Quick infos

  • Headquarters:   Dublin, Ohio, United States

Trade prices

  • Volume:
  • Market Cap: 20.15M
  • Prev closed: 1.27
  • Open: 3.12
  • High: 3.5
  • Low: 2.26
  • 52 week low: 0.49
  • 52 week high: 3.5
  • Dividends:No Dividends

Next ER: November 15, 2022  After Market Closes



Top Stories (NAVB)

    Company Profile

    Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) is a leader in precision medicine with immuno-targeted products designed to help identify the sites and pathways of undetected disease and enable better diagnostic accuracy, clinical decision-making, targeted treatment and, ultimately, patient care. Applying our Manocept? technology, Navidea seeks to develop next-generation targeted diagnostics and therapies for cancer, autoimmune conditions, and other inflammatory diseases. The company, founded in 1983, maintains headquarters in Dublin, Ohio.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    March 21, 2023
    November 14, 2022-0.25 / -7.52K / -Beat!
    August 15, 2022-0.1 / -57.53K / -Beat!
    May 12, 2022-0.1 / -57.53K / -Beat!
    March 23, 2022-0.12 / -0.0350.35K / 1.8MBeat!
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    May 12, 2022 0.7200 0.7546
    0.8400
    0.7200
    36.29K -7.1%
    May 11, 2022 0.7750 0.7809
    0.8439
    0.7710
    33.48K -2.04%
    May 10, 2022 0.7911 0.8600
    0.8941
    0.7220
    99.71K -7.83%
    May 9, 2022 0.8583 0.8796
    0.9200
    0.8300
    43.63K -2.6%
    May 6, 2022 0.8812 0.9164
    0.9164
    0.8307
    96.79K -5.2%
    May 5, 2022 0.9295 0.9550
    0.9550
    0.9014
    15.46K -3.99%
    May 4, 2022 0.9681 1.0300
    1.0300
    0.9120
    134.90K -6.01%
    May 3, 2022 1.0300 1.0000
    1.0300
    1.0000
    62.27K 3%
    May 2, 2022 1.0000 1.0100
    1.0400
    0.9700
    73.66K -2.91%
    Apr 29, 2022 1.0300 1.0400
    1.0400
    0.9400
    125.34K 0.98%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • ISIN: US6405181065
    • CUSIP: 640518106
    • Founded:1983
    • Employees:13

    News

    News for (NAVB)

    This company doesn't provide a dividend.


    Talk about Navidea Biopharmaceuticals, Inc. below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on Nov 15, 2022 (Same day)

    wmt hd aap vod enr armk bery goss optn tme vrex aqua 


    Jump to (Finance sites)

    Their Official Profiles 

    LinkedIn

    Peers / Similar stocks 

    xlv 

    Other stocks 

    crm cx c ma tgt pdco cag symc mtb chl cah tol 

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    Technical Analysis For Dummies
    Buy on Amazon

    Technical analysis is a collection of techniques designed to help you make trading decisions in securities markets. Technical Analysis For Dummies helps you take a hard-headed look at what securities prices are actually doing rather than what economists or analysts say they should be doing, giving you the know-how to use that data to decide whether to buy or sell individual securities.

    A simple, straightforward guide to the fundamentals of technical analysis